Literature DB >> 1374809

Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions.

P A Sherman1, M L Dickson, J A Fyfe.   

Abstract

Using purified integration protein (IN) from human immunodeficiency virus (HIV) type 1 and oligonucleotide mimics of viral and target DNA, we have investigated the DNA sequence specificity of the cleaving and joining reactions that take place during retroviral integration. The first reaction in this process is selective endonucleolytic cleaving of the viral DNA terminus that generates a recessed 3' OH group. This 3' OH group is then joined to a 5' phosphoryl group located at a break in the target DNA. We found that the conserved CA located close to the 3' end of the plus strand of the U5 viral terminus (also present on the minus strand of the U3 terminus) was required for both cleaving and joining reactions. Six bases of HIV U5 or U3 DNA at the ends of model substrates were sufficient for nearly maximal levels of selective endonucleolytic cleaving and joining. However, viral sequence elements upstream of the terminal 6 bases could also affect the efficiencies of the cleaving and joining reactions. The penultimate base (C) on the minus strand of HIV U5 was required for optimal joining activity. A synthetic oligonucleotide mimic of the putative in vivo viral "DNA" substrate for HIV IN, a molecule that contained a terminal adenosine 5'-phosphate (rA) on the minus strand, was indistinguishable in the cleaving and joining reactions from the DNA substrate containing deoxyadenosine instead of adenosine 5'-phosphate at the terminal position. Single-stranded DNA served as an in vitro integration target for HIV IN. The DNA sequence specificity of the joining reaction catalyzed in the reverse direction was also investigated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374809      PMCID: PMC241141     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.

Authors:  C M Farnet; W A Haseltine
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  A covalent complex between retroviral integrase and nicked substrate DNA.

Authors:  M Katzman; J P Mack; A M Skalka; J Leis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.

Authors:  C Vink; D C van Gent; Y Elgersma; R H Plasterk
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Integration of human immunodeficiency virus type 1 DNA in vitro.

Authors:  C M Farnet; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Sequence requirements for integration of Moloney murine leukemia virus DNA in vitro.

Authors:  F D Bushman; R Craigie
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Retroviral DNA integration directed by HIV integration protein in vitro.

Authors:  F D Bushman; T Fujiwara; R Craigie
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

7.  The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro.

Authors:  R Craigie; T Fujiwara; F Bushman
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

8.  The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration.

Authors:  M Katzman; R A Katz; A M Skalka; J Leis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site.

Authors:  J Colicelli; S P Goff
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

10.  Integration of mini-retroviral DNA: a cell-free reaction for biochemical analysis of retroviral integration.

Authors:  T Fujiwara; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more
  50 in total

1.  Substrate sequence selection by retroviral integrase.

Authors:  H Zhou; G J Rainey; S K Wong; J M Coffin
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Asymmetric processing of human immunodeficiency virus type 1 cDNA in vivo: implications for functional end coupling during the chemical steps of DNA transposition.

Authors:  H Chen; A Engelman
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

3.  Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration.

Authors:  H Chen; A Engelman
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Correct integration of model substrates by Ty1 integrase.

Authors:  S P Moore; D J Garfinkel
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Patterns of sequence conservation at termini of long terminal repeat (LTR) retrotransposons and DNA transposons in the human genome: lessons from phage Mu.

Authors:  Insuk Lee; Rasika M Harshey
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

6.  A high-throughput method for cloning and sequencing human immunodeficiency virus type 1 integration sites.

Authors:  Sanggu Kim; Yein Kim; Teresa Liang; Janet S Sinsheimer; Samson A Chow
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

7.  In vitro activities of purified visna virus integrase.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Substrate features important for recognition and catalysis by human immunodeficiency virus type 1 integrase identified by using novel DNA substrates.

Authors:  S A Chow; P O Brown
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli.

Authors:  C Vink; K H van der Linden; R H Plasterk
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.